Tag: Disaster Planning

CDC mandates face masks for public transportation, making refusal a violation of federal law

Editor's Note The Centers for Disease Control and Prevention (CDC), on January 29, issued a federal Public Health Order requiring all individuals to wear masks on nearly all forms of public transportation, and made refusal to wear a mask a violation of federal law. The Order mandates the use of…

Read More

By: Judy Mathias
February 1, 2021
Share

COVID-19 outcomes in hospitalized healthcare workers

Editor's Note In this study, US and Canadian researchers find that healthcare workers (HCWs) hospitalized with COVID-19 do not have poorer outcomes than non-HCWs, even though they are at higher risk of acquiring the disease. Included in the analysis were 1,790 patients (127 HCWs and 1,663 non-HCWs). After 3:1 propensity…

Read More

By: Judy Mathias
January 28, 2021
Share

ECRI issues 2021 Top 10 Health Technology Hazards, managing EUA devices tops list

Editor's Note ECRI , on January 28, issued its Top 10 Health Technology Hazards for 2021. First on the list is the complexity of managing devices that have Food & Drug Administration (FDA) emergency use authorization (EUA) because of the COVID-19 pandemic. ECRI experts caution that hospitals need to watch…

Read More

By: Judy Mathias
January 28, 2021
Share

T cells can attack many coronavirus targets, even on new variants

Editor's Note This study by researchers at La Jolla Institute for Immunology, La Jolla, California, finds that T cells fight SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the spike protein. By attacking the virus from many angles, the T cells can…

Read More

By: Judy Mathias
January 28, 2021
Share

FDA reduces N95 decontamination cycles from 20 to 4

Editor's Note The Food & Drug Administration (FDA), on January 22, lowered the number of times an N95 mask can be cleaned and reused to 4, down from a previous maximum of 20 reuses, the January 25 Fierce Biotec reports. The FDA reissued emergency use authorizations for 10 N95 decontamination…

Read More

By: Judy Mathias
January 28, 2021
Share

Effects of COVID-19 pandemic on pediatric anesthesiologists

Editor's Note This survey of members of the Society for Pediatric Anesthesia finds that COVID-19 has affected the personal and professional lives of pediatric anesthesiologists, with women and non-whites disproportionately affected. Of 561 respondents: 21.7% planned to change their clinical responsibilities, and 10.6% planned to decrease their professional working time…

Read More

By: Judy Mathias
January 27, 2021
Share

Survey finds 71% of employees concerned about vaccine side effects

Editor's Note A Welltok survey of 1,000 adults across the US finds that 71% of employees are worried about COVID-19 vaccine side effects, 60% of Americans have a vaccine brand preference, and 52% are worried about the vaccine supply, the January 25 Human Resource Executive reports. Employers, who are seen…

Read More

By: Judy Mathias
January 27, 2021
Share

Pandemic fatigue affecting mitigation efforts

Editor's Note This study, led by researchers from Johns Hopkins University School of Medicine, Baltimore, analyzed survey responses from 7,705 participants between April 1 and November 24, 2020, on their attitudes and resistance toward COVID-19 mitigation efforts. All US regions experienced decreases in COVID-19 mitigation efforts during this time period,…

Read More

By: Judy Mathias
January 26, 2021
Share

FDA revises EUAs for N95 decontamination systems

Editor's Note The Food and Drug Administration on January 21 reissued emergency use authorizations (EUAs) for 10 systems used to decontaminate N95 respirators used by healthcare personnel . The 10 systems are: Michigan State University Decontamination System Technical Safety Services VHP Decontamination System Stryker Sustainability Solutions VHP Decontamination System STERIS…

Read More

By: Judy Mathias
January 26, 2021
Share

CDC: Anaphylactic reactions after first dose of Pfizer-BioNTech vaccine

Editor's Note From December 14 to 23, 2020, after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) identified 21 case reports of anaphylaxis. Of those, 4 (19%) were hospitalized (including 3 in intensive care), and 17 (81%) were treated in…

Read More

By: Judy Mathias
January 25, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat